# PeptideScanner evidence objects: Bremelanotide

Every published version of the records placed with Bremelanotide, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json. Selected public evidence only; not medical advice.

- Objects: 32
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct00425256-bremelanotide-v1"></a>

## ClinicalTrials.gov record NCT00425256

> PeptideScanner retained ClinicalTrials.gov record NCT00425256 at 2026-07-30T22:15:58.882Z. Its registry update date was 2011-02-23, and PeptideScanner's reviewed identity mapping was bremelanotide.

- Evidence object: `story:clinicaltrials-gov-nct00425256-bremelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2011-02-23
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00425256-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#clinicaltrials-gov-nct00425256-bremelanotide-v1
- Content SHA-256: `db39159cecee675b8f5d3560f2ed44d8cb80737c278e9455ad916a244e90838b`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT00425256 ([`ctg-observation-nct00425256-2011-02-23-d21da880df78`](#source-ctg-observation-nct00425256-2011-02-23-d21da880df78))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00425256 at 2026-07-30T22:15:58.882Z. Its registry update date was 2011-02-23, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct00425256-2011-02-23-d21da880df78`](#source-ctg-observation-nct00425256-2011-02-23-d21da880df78))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00425256 at 2026-07-30T22:15:58.882Z. Its registry update date was 2011-02-23, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct00425256-2011-02-23-d21da880df78`](#source-ctg-observation-nct00425256-2011-02-23-d21da880df78))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00425256-2011-02-23-d21da880df78`](#source-ctg-observation-nct00425256-2011-02-23-d21da880df78))

### Sources

<a id="source-ctg-observation-nct00425256-2011-02-23-d21da880df78"></a>
- **ClinicalTrials.gov record NCT00425256 · retained source version 2011-02-23:d21da880df7817f242f51155f052b38107ef0f7607d253ce53a0c666e5eecd90** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00425256) (`ctg-observation-nct00425256-2011-02-23-d21da880df78`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00425256." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#clinicaltrials-gov-nct00425256-bremelanotide-v1 SHA-256: db39159cecee675b8f5d3560f2ed44d8cb80737c278e9455ad916a244e90838b.

---

<a id="clinicaltrials-gov-nct01382719-bremelanotide-v1"></a>

## ClinicalTrials.gov record NCT01382719

> PeptideScanner retained ClinicalTrials.gov record NCT01382719 at 2026-07-30T21:54:46.551Z. Its registry update date was 2014-12-18, and PeptideScanner's reviewed identity mapping was bremelanotide.

- Evidence object: `story:clinicaltrials-gov-nct01382719-bremelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2014-12-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01382719-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#clinicaltrials-gov-nct01382719-bremelanotide-v1
- Content SHA-256: `5081cd44efb208f66ec20982d6aaf18fa4d6138122ded33b5d2f0535cd9d24a2`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT01382719 ([`ctg-observation-nct01382719-2014-12-18-c43bfbd86298`](#source-ctg-observation-nct01382719-2014-12-18-c43bfbd86298))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01382719 at 2026-07-30T21:54:46.551Z. Its registry update date was 2014-12-18, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct01382719-2014-12-18-c43bfbd86298`](#source-ctg-observation-nct01382719-2014-12-18-c43bfbd86298))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01382719 at 2026-07-30T21:54:46.551Z. Its registry update date was 2014-12-18, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct01382719-2014-12-18-c43bfbd86298`](#source-ctg-observation-nct01382719-2014-12-18-c43bfbd86298))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01382719-2014-12-18-c43bfbd86298`](#source-ctg-observation-nct01382719-2014-12-18-c43bfbd86298))

### Sources

<a id="source-ctg-observation-nct01382719-2014-12-18-c43bfbd86298"></a>
- **ClinicalTrials.gov record NCT01382719 · retained source version 2014-12-18:c43bfbd8629888e71b7b2b18adcf425165b1cecad077c63a0aafae2c3da4d05a** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01382719) (`ctg-observation-nct01382719-2014-12-18-c43bfbd86298`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01382719." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#clinicaltrials-gov-nct01382719-bremelanotide-v1 SHA-256: 5081cd44efb208f66ec20982d6aaf18fa4d6138122ded33b5d2f0535cd9d24a2.

---

<a id="clinicaltrials-gov-nct03973047-bremelanotide-v1"></a>

## ClinicalTrials.gov record NCT03973047

> PeptideScanner retained ClinicalTrials.gov record NCT03973047 at 2026-07-30T19:40:58.916Z. Its registry update date was 2022-04-04, and PeptideScanner's reviewed identity mapping was bremelanotide.

- Evidence object: `story:clinicaltrials-gov-nct03973047-bremelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2022-04-04
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct03973047-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#clinicaltrials-gov-nct03973047-bremelanotide-v1
- Content SHA-256: `a55502428362360082360519bfe47fb932c3e947a814f44f09aed739b9c1a59e`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT03973047 ([`ctg-observation-nct03973047-2022-04-04-497b0f4b3810`](#source-ctg-observation-nct03973047-2022-04-04-497b0f4b3810))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT03973047 at 2026-07-30T19:40:58.916Z. Its registry update date was 2022-04-04, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct03973047-2022-04-04-497b0f4b3810`](#source-ctg-observation-nct03973047-2022-04-04-497b0f4b3810))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT03973047 at 2026-07-30T19:40:58.916Z. Its registry update date was 2022-04-04, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct03973047-2022-04-04-497b0f4b3810`](#source-ctg-observation-nct03973047-2022-04-04-497b0f4b3810))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct03973047-2022-04-04-497b0f4b3810`](#source-ctg-observation-nct03973047-2022-04-04-497b0f4b3810))

### Sources

<a id="source-ctg-observation-nct03973047-2022-04-04-497b0f4b3810"></a>
- **ClinicalTrials.gov record NCT03973047 · retained source version 2022-04-04:497b0f4b3810b80bcb52e7ad920e589233946a10ef53c3144ff39d185cd03b8a** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT03973047) (`ctg-observation-nct03973047-2022-04-04-497b0f4b3810`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT03973047." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#clinicaltrials-gov-nct03973047-bremelanotide-v1 SHA-256: a55502428362360082360519bfe47fb932c3e947a814f44f09aed739b9c1a59e.

---

<a id="clinicaltrials-gov-nct04179734-bremelanotide-v1"></a>

## ClinicalTrials.gov record NCT04179734

> PeptideScanner retained ClinicalTrials.gov record NCT04179734 at 2026-07-30T18:41:37.916Z. Its registry update date was 2024-08-09, and PeptideScanner's reviewed identity mapping was bremelanotide.

- Evidence object: `story:clinicaltrials-gov-nct04179734-bremelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-08-09
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-09-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04179734-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#clinicaltrials-gov-nct04179734-bremelanotide-v1
- Content SHA-256: `4749dc624c6481def9d9678ede6c4501a7c5cca80b79c15f56c10933543680b0`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT04179734 ([`ctg-observation-nct04179734-2024-08-09-79b9661c69e1`](#source-ctg-observation-nct04179734-2024-08-09-79b9661c69e1))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04179734 at 2026-07-30T18:41:37.916Z. Its registry update date was 2024-08-09, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct04179734-2024-08-09-79b9661c69e1`](#source-ctg-observation-nct04179734-2024-08-09-79b9661c69e1))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04179734 at 2026-07-30T18:41:37.916Z. Its registry update date was 2024-08-09, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct04179734-2024-08-09-79b9661c69e1`](#source-ctg-observation-nct04179734-2024-08-09-79b9661c69e1))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04179734-2024-08-09-79b9661c69e1`](#source-ctg-observation-nct04179734-2024-08-09-79b9661c69e1))

### Sources

<a id="source-ctg-observation-nct04179734-2024-08-09-79b9661c69e1"></a>
- **ClinicalTrials.gov record NCT04179734 · retained source version 2024-08-09:79b9661c69e108e38bcd1955d2662171cde81ed97eaa6463c49d55f1096a1652** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04179734) (`ctg-observation-nct04179734-2024-08-09-79b9661c69e1`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04179734." Version 1, published 2026-09-09. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#clinicaltrials-gov-nct04179734-bremelanotide-v1 SHA-256: 4749dc624c6481def9d9678ede6c4501a7c5cca80b79c15f56c10933543680b0.

---

<a id="clinicaltrials-gov-nct04943068-bremelanotide-v1"></a>

## ClinicalTrials.gov record NCT04943068

> PeptideScanner retained ClinicalTrials.gov record NCT04943068 at 2026-07-30T18:38:25.522Z. Its registry update date was 2024-11-13, and PeptideScanner's reviewed identity mapping was bremelanotide.

- Evidence object: `story:clinicaltrials-gov-nct04943068-bremelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-11-13
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04943068-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#clinicaltrials-gov-nct04943068-bremelanotide-v1
- Content SHA-256: `f538f1fe6aaff50a9521d316ffe86c5fc7ede3e1b631931cd4ef615e1b2c98b9`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT04943068 ([`ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4`](#source-ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04943068 at 2026-07-30T18:38:25.522Z. Its registry update date was 2024-11-13, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4`](#source-ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04943068 at 2026-07-30T18:38:25.522Z. Its registry update date was 2024-11-13, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4`](#source-ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4`](#source-ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4))

### Sources

<a id="source-ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4"></a>
- **ClinicalTrials.gov record NCT04943068 · retained source version 2024-11-13:a4b75fe3baf43e9306bfabc43d55ca8aca5455dbb3a0628eb40893874c0d6a48** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04943068) (`ctg-observation-nct04943068-2024-11-13-a4b75fe3baf4`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04943068." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#clinicaltrials-gov-nct04943068-bremelanotide-v1 SHA-256: f538f1fe6aaff50a9521d316ffe86c5fc7ede3e1b631931cd4ef615e1b2c98b9.

---

<a id="clinicaltrials-gov-nct05709444-bremelanotide-v1"></a>

## ClinicalTrials.gov record NCT05709444

> PeptideScanner retained ClinicalTrials.gov record NCT05709444 at 2026-07-30T18:39:33.780Z. Its registry update date was 2024-10-17, and PeptideScanner's reviewed identity mapping was bremelanotide.

- Evidence object: `story:clinicaltrials-gov-nct05709444-bremelanotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-10-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-08
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct05709444-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#clinicaltrials-gov-nct05709444-bremelanotide-v1
- Content SHA-256: `cc120bd46c973a0bdeade713c8d31c81d74c7765912972de6f6914a6d5d95d58`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT05709444 ([`ctg-observation-nct05709444-2024-10-17-355c6ec0c61a`](#source-ctg-observation-nct05709444-2024-10-17-355c6ec0c61a))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT05709444 at 2026-07-30T18:39:33.780Z. Its registry update date was 2024-10-17, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct05709444-2024-10-17-355c6ec0c61a`](#source-ctg-observation-nct05709444-2024-10-17-355c6ec0c61a))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT05709444 at 2026-07-30T18:39:33.780Z. Its registry update date was 2024-10-17, and PeptideScanner's reviewed identity mapping was bremelanotide. ([`ctg-observation-nct05709444-2024-10-17-355c6ec0c61a`](#source-ctg-observation-nct05709444-2024-10-17-355c6ec0c61a))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct05709444-2024-10-17-355c6ec0c61a`](#source-ctg-observation-nct05709444-2024-10-17-355c6ec0c61a))

### Sources

<a id="source-ctg-observation-nct05709444-2024-10-17-355c6ec0c61a"></a>
- **ClinicalTrials.gov record NCT05709444 · retained source version 2024-10-17:355c6ec0c61a08f2248f50ead340654fa4af8764c6912f671d11d5005be28de1** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT05709444) (`ctg-observation-nct05709444-2024-10-17-355c6ec0c61a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT05709444." Version 1, published 2026-08-08. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#clinicaltrials-gov-nct05709444-bremelanotide-v1 SHA-256: cc120bd46c973a0bdeade713c8d31c81d74c7765912972de6f6914a6d5d95d58.

---

<a id="dailymed-label-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1-v1"></a>

## Bremelanotide DailyMed SPL version 1

> DailyMed lists Structured Product Labeling version 1 for the reviewed Bremelanotide label family with a published date of 2025-11-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1:v1`
- Evidence domain: Regulatory
- Date in source: 2025-11-18
- Source checked: 2026-08-22
- Published by PeptideScanner: 2026-08-22
- Story landing page: https://peptidescanner.com/stories/dailymed-label-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#dailymed-label-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1-v1
- Content SHA-256: `8ae8ca45d9a9a5eb668616b37f1117a90daf41e4c96b1e3fbd31ced16d4fa242`

### Claims and source pins

#### Headline

Bremelanotide DailyMed SPL version 1 ([`dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1-history`](#source-dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1-history))

#### Summary

DailyMed lists Structured Product Labeling version 1 for the reviewed Bremelanotide label family with a published date of 2025-11-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1-history`](#source-dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 1 for the reviewed Bremelanotide label family with a published date of 2025-11-18. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1-history`](#source-dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1-history`](#source-dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1-history))

### Sources

<a id="source-dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1-history"></a>
- **DailyMed SPL SET ID f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf · SPL version 1 · published 2025-11-18 · retained ZIP SHA-256 deb36c45aeecfb5e78f4b9ff837af0dfa1d12acf404c2d0424a6c279343cc780** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf&version=1) (`dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Bremelanotide DailyMed SPL version 1." Version 1, published 2026-08-22. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#dailymed-label-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v1-v1 SHA-256: 8ae8ca45d9a9a5eb668616b37f1117a90daf41e4c96b1e3fbd31ced16d4fa242.

---

<a id="dailymed-label-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2-v1"></a>

## Bremelanotide DailyMed SPL version 2

> DailyMed lists Structured Product Labeling version 2 for the reviewed Bremelanotide label family with a published date of 2026-11-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.

- Evidence object: `story:dailymed-label-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2:v1`
- Evidence domain: Regulatory
- Date in source: 2026-11-09
- Source checked: 2026-11-15
- Published by PeptideScanner: 2026-11-15
- Story landing page: https://peptidescanner.com/stories/dailymed-label-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#dailymed-label-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2-v1
- Content SHA-256: `e9efeb208441b3a5980a8674c6972a902a68bd9424401d1c70d5f79feca979de`

### Claims and source pins

#### Headline

Bremelanotide DailyMed SPL version 2 ([`dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2-history`](#source-dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2-history))

#### Summary

DailyMed lists Structured Product Labeling version 2 for the reviewed Bremelanotide label family with a published date of 2026-11-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2-history`](#source-dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2-history))

#### Paragraph 1

DailyMed lists Structured Product Labeling version 2 for the reviewed Bremelanotide label family with a published date of 2026-11-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents. ([`dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2-history`](#source-dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2-history))

#### Paragraph 2

This page reports that DailyMed lists an available Structured Product Labeling version for the reviewed label family and links the exact historical ZIP. It does not reproduce label text, identify which sections changed, establish FDA approval, interpret safety or effectiveness, or provide medical guidance. ([`dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2-history`](#source-dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2-history))

### Sources

<a id="source-dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2-history"></a>
- **DailyMed SPL SET ID f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf · SPL version 2 · published 2026-11-09 · retained ZIP SHA-256 2d84defe0388e18a13e351e6f4957cd25c35ed9f63ba01085707c333cadb6db0** — DailyMed · U.S. National Library of Medicine; class A. [Open source](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?type=zip&setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf&version=2) (`dailymed-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2-history`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Bremelanotide DailyMed SPL version 2." Version 1, published 2026-11-15. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#dailymed-label-bremelanotide-f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf-v2-v1 SHA-256: e9efeb208441b3a5980a8674c6972a902a68bd9424401d1c70d5f79feca979de.

---

<a id="fda-drugs-nda210557-v1"></a>

## Drugs@FDA application NDA210557

> The official Drugs@FDA dataset lists original submission 1 for NDA 210557 with status AP dated 2019-06-21, and names bremelanotide acetate among the application record's active ingredients.

- Evidence object: `story:fda-drugs-nda210557:v1`
- Evidence domain: Regulatory
- Date in source: 2019-06-21
- Source checked: 2026-08-14
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/fda-drugs-nda210557/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#fda-drugs-nda210557-v1
- Content SHA-256: `8a77dab0f30208157da9f4e62958c6d76990072a188496d003b7f0936746592b`

### Claims and source pins

#### Headline

Drugs@FDA application NDA210557 ([`fda-drugs-nda210557-2019-06-21-d4c7e45d4a54`](#source-fda-drugs-nda210557-2019-06-21-d4c7e45d4a54))

#### Summary

The official Drugs@FDA dataset lists original submission 1 for NDA 210557 with status AP dated 2019-06-21, and names bremelanotide acetate among the application record's active ingredients. ([`fda-drugs-nda210557-2019-06-21-d4c7e45d4a54`](#source-fda-drugs-nda210557-2019-06-21-d4c7e45d4a54))

#### Paragraph 1

The official Drugs@FDA dataset lists original submission 1 for NDA 210557 with status AP dated 2019-06-21, and names bremelanotide acetate among the application record's active ingredients. ([`fda-drugs-nda210557-2019-06-21-d4c7e45d4a54`](#source-fda-drugs-nda210557-2019-06-21-d4c7e45d4a54))

#### Paragraph 2

This page reports bounded application metadata attributed to Drugs@FDA. It does not reproduce labeling, describe an indication, compare products, or provide medical guidance. ([`fda-drugs-nda210557-2019-06-21-d4c7e45d4a54`](#source-fda-drugs-nda210557-2019-06-21-d4c7e45d4a54))

### Sources

<a id="source-fda-drugs-nda210557-2019-06-21-d4c7e45d4a54"></a>
- **Drugs@FDA application NDA210557 · original submission status AP · 2019-06-21 · dataset 2026-08-13** — Drugs@FDA via openFDA; class A. [Open source](https://api.fda.gov/drug/drugsfda.json?search=application_number%3A%22NDA210557%22&limit=1) (`fda-drugs-nda210557-2019-06-21-d4c7e45d4a54`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Drugs@FDA application NDA210557." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#fda-drugs-nda210557-v1 SHA-256: 8a77dab0f30208157da9f4e62958c6d76990072a188496d003b7f0936746592b.

---

<a id="federal-register-2020-18240-v1"></a>

## Federal Register notice 2020-18240

> The Federal Register published notice 2020-18240, attributed to FDA and its parent HHS department, on 2020-08-20. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; VYLEESI,” and PeptideScanner's exact reviewed identity mapping connects the document to Bremelanotide.

- Evidence object: `story:federal-register-2020-18240:v1`
- Evidence domain: Regulatory
- Date in source: 2020-08-20
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-2020-18240/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#federal-register-2020-18240-v1
- Content SHA-256: `1cebcd2a8ef9278bcbaad95f6785961dfa469a14018df05bad75fd9960c711dc`

### Claims and source pins

#### Headline

Federal Register notice 2020-18240 ([`federal-register-2020-18240-d7fd5f66e436`](#source-federal-register-2020-18240-d7fd5f66e436))

#### Summary

The Federal Register published notice 2020-18240, attributed to FDA and its parent HHS department, on 2020-08-20. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; VYLEESI,” and PeptideScanner's exact reviewed identity mapping connects the document to Bremelanotide. ([`federal-register-2020-18240-d7fd5f66e436`](#source-federal-register-2020-18240-d7fd5f66e436))

#### Paragraph 1

The Federal Register published notice 2020-18240, attributed to FDA and its parent HHS department, on 2020-08-20. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; VYLEESI,” and PeptideScanner's exact reviewed identity mapping connects the document to Bremelanotide. ([`federal-register-2020-18240-d7fd5f66e436`](#source-federal-register-2020-18240-d7fd5f66e436))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-2020-18240-d7fd5f66e436`](#source-federal-register-2020-18240-d7fd5f66e436))

### Sources

<a id="source-federal-register-2020-18240-d7fd5f66e436"></a>
- **Federal Register notice 2020-18240 · published 2020-08-20 · Determination of Regulatory Review Period for Purposes of Patent Extension; VYLEESI** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2020-08-20/pdf/2020-18240.pdf) (`federal-register-2020-18240-d7fd5f66e436`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register notice 2020-18240." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#federal-register-2020-18240-v1 SHA-256: 1cebcd2a8ef9278bcbaad95f6785961dfa469a14018df05bad75fd9960c711dc.

---

<a id="federal-register-2021-06202-v1"></a>

## Federal Register notice 2021-06202

> The Federal Register published notice 2021-06202, attributed to FDA and its parent HHS department, on 2021-03-25. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Bremelanotide and Octreotide.

- Evidence object: `story:federal-register-2021-06202:v1`
- Evidence domain: Regulatory
- Date in source: 2021-03-25
- Source checked: 2026-08-21
- Published by PeptideScanner: 2026-08-21
- Story landing page: https://peptidescanner.com/stories/federal-register-2021-06202/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#federal-register-2021-06202-v1
- Content SHA-256: `e9806766e56b69afacc6d499e06c31938d3f9163e015aa77a0c8d2c5eb1cda6f`

### Claims and source pins

#### Headline

Federal Register notice 2021-06202 ([`federal-register-2021-06202-fdcc91c08a19`](#source-federal-register-2021-06202-fdcc91c08a19))

#### Summary

The Federal Register published notice 2021-06202, attributed to FDA and its parent HHS department, on 2021-03-25. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Bremelanotide and Octreotide. ([`federal-register-2021-06202-fdcc91c08a19`](#source-federal-register-2021-06202-fdcc91c08a19))

#### Paragraph 1

The Federal Register published notice 2021-06202, attributed to FDA and its parent HHS department, on 2021-03-25. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Bremelanotide and Octreotide. ([`federal-register-2021-06202-fdcc91c08a19`](#source-federal-register-2021-06202-fdcc91c08a19))

#### Paragraph 2

This page reports bounded metadata from a Federal Register document attributed to FDA and its parent HHS department, and links to the official GovInfo PDF. It does not interpret legal effect, approval, safety, effectiveness, compounding status, or medical use. ([`federal-register-2021-06202-fdcc91c08a19`](#source-federal-register-2021-06202-fdcc91c08a19))

### Sources

<a id="source-federal-register-2021-06202-fdcc91c08a19"></a>
- **Federal Register notice 2021-06202 · published 2021-03-25 · Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability** — Federal Register via GovInfo; class A. [Open source](https://www.govinfo.gov/content/pkg/FR-2021-03-25/pdf/2021-06202.pdf) (`federal-register-2021-06202-fdcc91c08a19`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Federal Register notice 2021-06202." Version 1, published 2026-08-21. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#federal-register-2021-06202-v1 SHA-256: e9806766e56b69afacc6d499e06c31938d3f9163e015aa77a0c8d2c5eb1cda6f.

---

<a id="pubmed-pmid-12851303-bremelanotide-v1"></a>

## PubMed record PMID 12851303

> PeptideScanner retained PubMed bibliographic metadata for PMID 12851303 at 2026-07-30T20:51:53.921Z. PubMed recorded a metadata revision date of 2019-06-16 and an Entrez history date of 2003-07-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-12851303-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-06-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-12851303-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-12851303-bremelanotide-v1
- Content SHA-256: `cc82e8e4effdc0f81a516aa42aabc01f5cfed9fe8dfe39978834762f91b9b407`

### Claims and source pins

#### Headline

PubMed record PMID 12851303 ([`pubmed-observation-pmid-12851303-2019-06-16-dadc1780d730`](#source-pubmed-observation-pmid-12851303-2019-06-16-dadc1780d730))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 12851303 at 2026-07-30T20:51:53.921Z. PubMed recorded a metadata revision date of 2019-06-16 and an Entrez history date of 2003-07-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-12851303-2019-06-16-dadc1780d730`](#source-pubmed-observation-pmid-12851303-2019-06-16-dadc1780d730))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 12851303 at 2026-07-30T20:51:53.921Z. PubMed recorded a metadata revision date of 2019-06-16 and an Entrez history date of 2003-07-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-12851303-2019-06-16-dadc1780d730`](#source-pubmed-observation-pmid-12851303-2019-06-16-dadc1780d730))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-12851303-2019-06-16-dadc1780d730`](#source-pubmed-observation-pmid-12851303-2019-06-16-dadc1780d730))

### Sources

<a id="source-pubmed-observation-pmid-12851303-2019-06-16-dadc1780d730"></a>
- **PubMed record PMID 12851303 · retained source version 1:2019-06-16:current:dadc1780d730ddf4c85c5a6e341d7a0a9ce3fd9b65d4d79c85f27d3b2586a7d3** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/12851303/) (`pubmed-observation-pmid-12851303-2019-06-16-dadc1780d730`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 12851303." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-12851303-bremelanotide-v1 SHA-256: cc82e8e4effdc0f81a516aa42aabc01f5cfed9fe8dfe39978834762f91b9b407.

---

<a id="pubmed-pmid-14963471-bremelanotide-v1"></a>

## PubMed record PMID 14963471

> PeptideScanner retained PubMed bibliographic metadata for PMID 14963471 at 2026-07-30T21:55:37.950Z. PubMed recorded a metadata revision date of 2014-11-20 and an Entrez history date of 2004-02-14. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-14963471-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2014-11-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-14963471-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-14963471-bremelanotide-v1
- Content SHA-256: `0fc9d38cd3454c6604f9020907500af8bc52ebde5881d06a46f7be9ea3851056`

### Claims and source pins

#### Headline

PubMed record PMID 14963471 ([`pubmed-observation-pmid-14963471-2014-11-20-442dfeafa9ea`](#source-pubmed-observation-pmid-14963471-2014-11-20-442dfeafa9ea))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 14963471 at 2026-07-30T21:55:37.950Z. PubMed recorded a metadata revision date of 2014-11-20 and an Entrez history date of 2004-02-14. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-14963471-2014-11-20-442dfeafa9ea`](#source-pubmed-observation-pmid-14963471-2014-11-20-442dfeafa9ea))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 14963471 at 2026-07-30T21:55:37.950Z. PubMed recorded a metadata revision date of 2014-11-20 and an Entrez history date of 2004-02-14. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-14963471-2014-11-20-442dfeafa9ea`](#source-pubmed-observation-pmid-14963471-2014-11-20-442dfeafa9ea))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-14963471-2014-11-20-442dfeafa9ea`](#source-pubmed-observation-pmid-14963471-2014-11-20-442dfeafa9ea))

### Sources

<a id="source-pubmed-observation-pmid-14963471-2014-11-20-442dfeafa9ea"></a>
- **PubMed record PMID 14963471 · retained source version 1:2014-11-20:current:442dfeafa9eae7e335122daa86088d96640e35c5ab79246c37577e378ebac147** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/14963471/) (`pubmed-observation-pmid-14963471-2014-11-20-442dfeafa9ea`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 14963471." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-14963471-bremelanotide-v1 SHA-256: 0fc9d38cd3454c6604f9020907500af8bc52ebde5881d06a46f7be9ea3851056.

---

<a id="pubmed-pmid-14999221-bremelanotide-v1"></a>

## PubMed record PMID 14999221

> PeptideScanner retained PubMed bibliographic metadata for PMID 14999221 at 2026-07-30T21:41:07.288Z. PubMed recorded a metadata revision date of 2015-11-19 and an Entrez history date of 2004-03-05. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-14999221-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2015-11-19
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-14999221-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-14999221-bremelanotide-v1
- Content SHA-256: `d239311317cc8f886604a1b7521be77f1f9d60633ee47d054eefbe562685c23a`

### Claims and source pins

#### Headline

PubMed record PMID 14999221 ([`pubmed-observation-pmid-14999221-2015-11-19-b9ac9afeea5a`](#source-pubmed-observation-pmid-14999221-2015-11-19-b9ac9afeea5a))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 14999221 at 2026-07-30T21:41:07.288Z. PubMed recorded a metadata revision date of 2015-11-19 and an Entrez history date of 2004-03-05. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-14999221-2015-11-19-b9ac9afeea5a`](#source-pubmed-observation-pmid-14999221-2015-11-19-b9ac9afeea5a))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 14999221 at 2026-07-30T21:41:07.288Z. PubMed recorded a metadata revision date of 2015-11-19 and an Entrez history date of 2004-03-05. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-14999221-2015-11-19-b9ac9afeea5a`](#source-pubmed-observation-pmid-14999221-2015-11-19-b9ac9afeea5a))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-14999221-2015-11-19-b9ac9afeea5a`](#source-pubmed-observation-pmid-14999221-2015-11-19-b9ac9afeea5a))

### Sources

<a id="source-pubmed-observation-pmid-14999221-2015-11-19-b9ac9afeea5a"></a>
- **PubMed record PMID 14999221 · retained source version 1:2015-11-19:current:b9ac9afeea5ac8730cc8e4c85afcc358db01edf86615a53506c165aac81080c8** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/14999221/) (`pubmed-observation-pmid-14999221-2015-11-19-b9ac9afeea5a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 14999221." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-14999221-bremelanotide-v1 SHA-256: d239311317cc8f886604a1b7521be77f1f9d60633ee47d054eefbe562685c23a.

---

<a id="pubmed-pmid-15134289-bremelanotide-v1"></a>

## PubMed record PMID 15134289

> PeptideScanner retained PubMed bibliographic metadata for PMID 15134289 at 2026-07-30T21:55:37.950Z. PubMed recorded a metadata revision date of 2014-11-20 and an Entrez history date of 2004-05-12. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-15134289-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2014-11-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-15134289-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-15134289-bremelanotide-v1
- Content SHA-256: `6551a5db29326c78919f74a95018f9dbd054e9b60fa1ea0209742ec89d3ab2e3`

### Claims and source pins

#### Headline

PubMed record PMID 15134289 ([`pubmed-observation-pmid-15134289-2014-11-20-2e343cfbb525`](#source-pubmed-observation-pmid-15134289-2014-11-20-2e343cfbb525))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 15134289 at 2026-07-30T21:55:37.950Z. PubMed recorded a metadata revision date of 2014-11-20 and an Entrez history date of 2004-05-12. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-15134289-2014-11-20-2e343cfbb525`](#source-pubmed-observation-pmid-15134289-2014-11-20-2e343cfbb525))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 15134289 at 2026-07-30T21:55:37.950Z. PubMed recorded a metadata revision date of 2014-11-20 and an Entrez history date of 2004-05-12. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-15134289-2014-11-20-2e343cfbb525`](#source-pubmed-observation-pmid-15134289-2014-11-20-2e343cfbb525))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-15134289-2014-11-20-2e343cfbb525`](#source-pubmed-observation-pmid-15134289-2014-11-20-2e343cfbb525))

### Sources

<a id="source-pubmed-observation-pmid-15134289-2014-11-20-2e343cfbb525"></a>
- **PubMed record PMID 15134289 · retained source version 1:2014-11-20:current:2e343cfbb525844641737f4b356583c70beaa49d655d9233fea1666775d342ac** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/15134289/) (`pubmed-observation-pmid-15134289-2014-11-20-2e343cfbb525`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 15134289." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-15134289-bremelanotide-v1 SHA-256: 6551a5db29326c78919f74a95018f9dbd054e9b60fa1ea0209742ec89d3ab2e3.

---

<a id="pubmed-pmid-15833522-bremelanotide-v1"></a>

## PubMed record PMID 15833522

> PeptideScanner retained PubMed bibliographic metadata for PMID 15833522 at 2026-07-30T21:41:07.293Z. PubMed recorded a metadata revision date of 2015-11-19 and an Entrez history date of 2005-04-19. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-15833522-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2015-11-19
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-10
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-15833522-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-15833522-bremelanotide-v1
- Content SHA-256: `e11cbda70bec3afedc7b6c17ad623c8aa0bb56ab80927a76a2bc73cacd0b5ba3`

### Claims and source pins

#### Headline

PubMed record PMID 15833522 ([`pubmed-observation-pmid-15833522-2015-11-19-f9dfa4a59d68`](#source-pubmed-observation-pmid-15833522-2015-11-19-f9dfa4a59d68))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 15833522 at 2026-07-30T21:41:07.293Z. PubMed recorded a metadata revision date of 2015-11-19 and an Entrez history date of 2005-04-19. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-15833522-2015-11-19-f9dfa4a59d68`](#source-pubmed-observation-pmid-15833522-2015-11-19-f9dfa4a59d68))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 15833522 at 2026-07-30T21:41:07.293Z. PubMed recorded a metadata revision date of 2015-11-19 and an Entrez history date of 2005-04-19. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-15833522-2015-11-19-f9dfa4a59d68`](#source-pubmed-observation-pmid-15833522-2015-11-19-f9dfa4a59d68))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-15833522-2015-11-19-f9dfa4a59d68`](#source-pubmed-observation-pmid-15833522-2015-11-19-f9dfa4a59d68))

### Sources

<a id="source-pubmed-observation-pmid-15833522-2015-11-19-f9dfa4a59d68"></a>
- **PubMed record PMID 15833522 · retained source version 1:2015-11-19:current:f9dfa4a59d68a0db7ff71a564a0132d35129dcb28eb7205813ddc670cc28e96b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/15833522/) (`pubmed-observation-pmid-15833522-2015-11-19-f9dfa4a59d68`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 15833522." Version 1, published 2026-08-10. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-15833522-bremelanotide-v1 SHA-256: e11cbda70bec3afedc7b6c17ad623c8aa0bb56ab80927a76a2bc73cacd0b5ba3.

---

<a id="pubmed-pmid-16839319-bremelanotide-v1"></a>

## PubMed record PMID 16839319

> PeptideScanner retained PubMed bibliographic metadata for PMID 16839319 at 2026-07-30T21:22:56.974Z. PubMed recorded a metadata revision date of 2017-10-16 and an Entrez history date of 2006-07-15. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-16839319-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2017-10-16
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-16839319-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-16839319-bremelanotide-v1
- Content SHA-256: `6558f92c97239ed76523547e48ba0cf48027bc0a7f77c8baf806cc5ea861f99a`

### Claims and source pins

#### Headline

PubMed record PMID 16839319 ([`pubmed-observation-pmid-16839319-2017-10-16-1a7361aa129a`](#source-pubmed-observation-pmid-16839319-2017-10-16-1a7361aa129a))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 16839319 at 2026-07-30T21:22:56.974Z. PubMed recorded a metadata revision date of 2017-10-16 and an Entrez history date of 2006-07-15. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-16839319-2017-10-16-1a7361aa129a`](#source-pubmed-observation-pmid-16839319-2017-10-16-1a7361aa129a))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 16839319 at 2026-07-30T21:22:56.974Z. PubMed recorded a metadata revision date of 2017-10-16 and an Entrez history date of 2006-07-15. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-16839319-2017-10-16-1a7361aa129a`](#source-pubmed-observation-pmid-16839319-2017-10-16-1a7361aa129a))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-16839319-2017-10-16-1a7361aa129a`](#source-pubmed-observation-pmid-16839319-2017-10-16-1a7361aa129a))

### Sources

<a id="source-pubmed-observation-pmid-16839319-2017-10-16-1a7361aa129a"></a>
- **PubMed record PMID 16839319 · retained source version 1:2017-10-16:current:1a7361aa129a660072c9419585d8f6ac6db823af154b58eaff24da54d9193a01** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/16839319/) (`pubmed-observation-pmid-16839319-2017-10-16-1a7361aa129a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 16839319." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-16839319-bremelanotide-v1 SHA-256: 6558f92c97239ed76523547e48ba0cf48027bc0a7f77c8baf806cc5ea861f99a.

---

<a id="pubmed-pmid-27751477-bremelanotide-v1"></a>

## PubMed record PMID 27751477

> PeptideScanner retained PubMed bibliographic metadata for PMID 27751477 at 2026-07-30T21:09:23.546Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2016-10-19. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-27751477-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-02
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27751477-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-27751477-bremelanotide-v1
- Content SHA-256: `6fe8034a90f78b86cb22003eb0a337327c11b69289cb4c1e7f886a54ba5f9a91`

### Claims and source pins

#### Headline

PubMed record PMID 27751477 ([`pubmed-observation-pmid-27751477-2018-12-02-d51856360ebf`](#source-pubmed-observation-pmid-27751477-2018-12-02-d51856360ebf))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 27751477 at 2026-07-30T21:09:23.546Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2016-10-19. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-27751477-2018-12-02-d51856360ebf`](#source-pubmed-observation-pmid-27751477-2018-12-02-d51856360ebf))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 27751477 at 2026-07-30T21:09:23.546Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2016-10-19. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-27751477-2018-12-02-d51856360ebf`](#source-pubmed-observation-pmid-27751477-2018-12-02-d51856360ebf))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27751477-2018-12-02-d51856360ebf`](#source-pubmed-observation-pmid-27751477-2018-12-02-d51856360ebf))

### Sources

<a id="source-pubmed-observation-pmid-27751477-2018-12-02-d51856360ebf"></a>
- **PubMed record PMID 27751477 · retained source version 1:2018-12-02:current:d51856360ebf33f0ccbce619f379cc298c887a99550cac0c04335edd235d5233** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27751477/) (`pubmed-observation-pmid-27751477-2018-12-02-d51856360ebf`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 27751477." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-27751477-bremelanotide-v1 SHA-256: 6fe8034a90f78b86cb22003eb0a337327c11b69289cb4c1e7f886a54ba5f9a91.

---

<a id="pubmed-pmid-27977473-bremelanotide-v1"></a>

## PubMed record PMID 27977473

> PeptideScanner retained PubMed bibliographic metadata for PMID 27977473 at 2026-07-30T21:09:23.592Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2016-12-16. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-27977473-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-02
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-27977473-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-27977473-bremelanotide-v1
- Content SHA-256: `4441492e38d24e5fb1f588f4755ad5804ecba08c68abe23527cd750c02fe6507`

### Claims and source pins

#### Headline

PubMed record PMID 27977473 ([`pubmed-observation-pmid-27977473-2018-12-02-f76c4fa18d0c`](#source-pubmed-observation-pmid-27977473-2018-12-02-f76c4fa18d0c))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 27977473 at 2026-07-30T21:09:23.592Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2016-12-16. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-27977473-2018-12-02-f76c4fa18d0c`](#source-pubmed-observation-pmid-27977473-2018-12-02-f76c4fa18d0c))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 27977473 at 2026-07-30T21:09:23.592Z. PubMed recorded a metadata revision date of 2018-12-02 and an Entrez history date of 2016-12-16. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-27977473-2018-12-02-f76c4fa18d0c`](#source-pubmed-observation-pmid-27977473-2018-12-02-f76c4fa18d0c))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-27977473-2018-12-02-f76c4fa18d0c`](#source-pubmed-observation-pmid-27977473-2018-12-02-f76c4fa18d0c))

### Sources

<a id="source-pubmed-observation-pmid-27977473-2018-12-02-f76c4fa18d0c"></a>
- **PubMed record PMID 27977473 · retained source version 1:2018-12-02:current:f76c4fa18d0c8ac0c024dd7b0bf3c491eab60cba3a8550597f75465b5b55e838** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/27977473/) (`pubmed-observation-pmid-27977473-2018-12-02-f76c4fa18d0c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 27977473." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-27977473-bremelanotide-v1 SHA-256: 4441492e38d24e5fb1f588f4755ad5804ecba08c68abe23527cd750c02fe6507.

---

<a id="pubmed-pmid-28189361-bremelanotide-v1"></a>

## PubMed record PMID 28189361

> PeptideScanner retained PubMed bibliographic metadata for PMID 28189361 at 2026-07-30T20:55:52.311Z. PubMed recorded a metadata revision date of 2019-03-18 and an Entrez history date of 2017-02-13. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-28189361-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-03-18
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-28189361-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-28189361-bremelanotide-v1
- Content SHA-256: `b59061ad853101cb2369c3f9f01582908d21c718b278bb5290b2eca91841b6de`

### Claims and source pins

#### Headline

PubMed record PMID 28189361 ([`pubmed-observation-pmid-28189361-2019-03-18-9dc5a63edf62`](#source-pubmed-observation-pmid-28189361-2019-03-18-9dc5a63edf62))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 28189361 at 2026-07-30T20:55:52.311Z. PubMed recorded a metadata revision date of 2019-03-18 and an Entrez history date of 2017-02-13. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-28189361-2019-03-18-9dc5a63edf62`](#source-pubmed-observation-pmid-28189361-2019-03-18-9dc5a63edf62))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 28189361 at 2026-07-30T20:55:52.311Z. PubMed recorded a metadata revision date of 2019-03-18 and an Entrez history date of 2017-02-13. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-28189361-2019-03-18-9dc5a63edf62`](#source-pubmed-observation-pmid-28189361-2019-03-18-9dc5a63edf62))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-28189361-2019-03-18-9dc5a63edf62`](#source-pubmed-observation-pmid-28189361-2019-03-18-9dc5a63edf62))

### Sources

<a id="source-pubmed-observation-pmid-28189361-2019-03-18-9dc5a63edf62"></a>
- **PubMed record PMID 28189361 · retained source version 1:2019-03-18:current:9dc5a63edf62c13d835f33f2d712d5d2ed526a72f0b45795bf5dffd913e2ad50** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/28189361/) (`pubmed-observation-pmid-28189361-2019-03-18-9dc5a63edf62`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 28189361." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-28189361-bremelanotide-v1 SHA-256: b59061ad853101cb2369c3f9f01582908d21c718b278bb5290b2eca91841b6de.

---

<a id="pubmed-pmid-30290453-bremelanotide-v1"></a>

## PubMed record PMID 30290453

> PeptideScanner retained PubMed bibliographic metadata for PMID 30290453 at 2026-07-30T20:44:20.566Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2018-10-07. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-30290453-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-11-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30290453-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-30290453-bremelanotide-v1
- Content SHA-256: `05972f555c3f8e1237ff81f3e793cea31cf93814b9e59e85158c4dda6498da19`

### Claims and source pins

#### Headline

PubMed record PMID 30290453 ([`pubmed-observation-pmid-30290453-2019-11-20-afa85df8eb28`](#source-pubmed-observation-pmid-30290453-2019-11-20-afa85df8eb28))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 30290453 at 2026-07-30T20:44:20.566Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2018-10-07. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-30290453-2019-11-20-afa85df8eb28`](#source-pubmed-observation-pmid-30290453-2019-11-20-afa85df8eb28))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 30290453 at 2026-07-30T20:44:20.566Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2018-10-07. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-30290453-2019-11-20-afa85df8eb28`](#source-pubmed-observation-pmid-30290453-2019-11-20-afa85df8eb28))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30290453-2019-11-20-afa85df8eb28`](#source-pubmed-observation-pmid-30290453-2019-11-20-afa85df8eb28))

### Sources

<a id="source-pubmed-observation-pmid-30290453-2019-11-20-afa85df8eb28"></a>
- **PubMed record PMID 30290453 · retained source version 1:2019-11-20:current:afa85df8eb28305ba3c6886ad33d3d83258713beda56ffabd3b41d6840cc9a88** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30290453/) (`pubmed-observation-pmid-30290453-2019-11-20-afa85df8eb28`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 30290453." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-30290453-bremelanotide-v1 SHA-256: 05972f555c3f8e1237ff81f3e793cea31cf93814b9e59e85158c4dda6498da19.

---

<a id="pubmed-pmid-31277966-bremelanotide-v1"></a>

## PubMed record PMID 31277966

> PeptideScanner retained PubMed bibliographic metadata for PMID 31277966 at 2026-07-30T20:27:29.445Z. PubMed recorded a metadata revision date of 2020-06-29 and an Entrez history date of 2019-07-07. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-31277966-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2020-06-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-31277966-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-31277966-bremelanotide-v1
- Content SHA-256: `9ece8fbb3636bc5a24a9a66a5795ed20e82f2b3af05891465553a59ec145f5c4`

### Claims and source pins

#### Headline

PubMed record PMID 31277966 ([`pubmed-observation-pmid-31277966-2020-06-29-fd8b0908310d`](#source-pubmed-observation-pmid-31277966-2020-06-29-fd8b0908310d))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 31277966 at 2026-07-30T20:27:29.445Z. PubMed recorded a metadata revision date of 2020-06-29 and an Entrez history date of 2019-07-07. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-31277966-2020-06-29-fd8b0908310d`](#source-pubmed-observation-pmid-31277966-2020-06-29-fd8b0908310d))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 31277966 at 2026-07-30T20:27:29.445Z. PubMed recorded a metadata revision date of 2020-06-29 and an Entrez history date of 2019-07-07. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-31277966-2020-06-29-fd8b0908310d`](#source-pubmed-observation-pmid-31277966-2020-06-29-fd8b0908310d))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-31277966-2020-06-29-fd8b0908310d`](#source-pubmed-observation-pmid-31277966-2020-06-29-fd8b0908310d))

### Sources

<a id="source-pubmed-observation-pmid-31277966-2020-06-29-fd8b0908310d"></a>
- **PubMed record PMID 31277966 · retained source version 1:2020-06-29:current:fd8b0908310d7e8cd7f6da9b741d41f469f1a08c6f9301f512a4b3665920422f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/31277966/) (`pubmed-observation-pmid-31277966-2020-06-29-fd8b0908310d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 31277966." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-31277966-bremelanotide-v1 SHA-256: 9ece8fbb3636bc5a24a9a66a5795ed20e82f2b3af05891465553a59ec145f5c4.

---

<a id="pubmed-pmid-31381550-bremelanotide-v1"></a>

## PubMed record PMID 31381550

> PeptideScanner retained PubMed bibliographic metadata for PMID 31381550 at 2026-07-30T20:44:20.977Z. PubMed recorded a metadata revision date of 2019-11-08 and an Entrez history date of 2019-08-06. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-31381550-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-11-08
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-31381550-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-31381550-bremelanotide-v1
- Content SHA-256: `45693c86df0e50a155ed81b5215534c461852b89d11335e9435d2a68c4038918`

### Claims and source pins

#### Headline

PubMed record PMID 31381550 ([`pubmed-observation-pmid-31381550-2019-11-08-e542b6525d4a`](#source-pubmed-observation-pmid-31381550-2019-11-08-e542b6525d4a))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 31381550 at 2026-07-30T20:44:20.977Z. PubMed recorded a metadata revision date of 2019-11-08 and an Entrez history date of 2019-08-06. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-31381550-2019-11-08-e542b6525d4a`](#source-pubmed-observation-pmid-31381550-2019-11-08-e542b6525d4a))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 31381550 at 2026-07-30T20:44:20.977Z. PubMed recorded a metadata revision date of 2019-11-08 and an Entrez history date of 2019-08-06. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-31381550-2019-11-08-e542b6525d4a`](#source-pubmed-observation-pmid-31381550-2019-11-08-e542b6525d4a))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-31381550-2019-11-08-e542b6525d4a`](#source-pubmed-observation-pmid-31381550-2019-11-08-e542b6525d4a))

### Sources

<a id="source-pubmed-observation-pmid-31381550-2019-11-08-e542b6525d4a"></a>
- **PubMed record PMID 31381550 · retained source version 1:2019-11-08:current:e542b6525d4afe8de8d2d4258876973b01fdf24b0534c2e04d7a4fb273a76ebd** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/31381550/) (`pubmed-observation-pmid-31381550-2019-11-08-e542b6525d4a`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 31381550." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-31381550-bremelanotide-v1 SHA-256: 45693c86df0e50a155ed81b5215534c461852b89d11335e9435d2a68c4038918.

---

<a id="pubmed-pmid-31429064-bremelanotide-v1"></a>

## PubMed record PMID 31429064

> PeptideScanner retained PubMed bibliographic metadata for PMID 31429064 at 2026-07-30T20:33:07.992Z. PubMed recorded a metadata revision date of 2020-02-25 and an Entrez history date of 2019-08-21. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-31429064-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2020-02-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-31429064-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-31429064-bremelanotide-v1
- Content SHA-256: `55d69152952a314e5f64e8801383f8b2831b084a4a6a0d162f12fbefbb5bfad8`

### Claims and source pins

#### Headline

PubMed record PMID 31429064 ([`pubmed-observation-pmid-31429064-2020-02-25-93c118c27c88`](#source-pubmed-observation-pmid-31429064-2020-02-25-93c118c27c88))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 31429064 at 2026-07-30T20:33:07.992Z. PubMed recorded a metadata revision date of 2020-02-25 and an Entrez history date of 2019-08-21. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-31429064-2020-02-25-93c118c27c88`](#source-pubmed-observation-pmid-31429064-2020-02-25-93c118c27c88))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 31429064 at 2026-07-30T20:33:07.992Z. PubMed recorded a metadata revision date of 2020-02-25 and an Entrez history date of 2019-08-21. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-31429064-2020-02-25-93c118c27c88`](#source-pubmed-observation-pmid-31429064-2020-02-25-93c118c27c88))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-31429064-2020-02-25-93c118c27c88`](#source-pubmed-observation-pmid-31429064-2020-02-25-93c118c27c88))

### Sources

<a id="source-pubmed-observation-pmid-31429064-2020-02-25-93c118c27c88"></a>
- **PubMed record PMID 31429064 · retained source version 1:2020-02-25:current:93c118c27c88ff5d9345033e23b27739e7c288e4083584b0669c7b08747d2c67** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/31429064/) (`pubmed-observation-pmid-31429064-2020-02-25-93c118c27c88`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 31429064." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-31429064-bremelanotide-v1 SHA-256: 55d69152952a314e5f64e8801383f8b2831b084a4a6a0d162f12fbefbb5bfad8.

---

<a id="pubmed-pmid-32353679-bremelanotide-v1"></a>

## Ultra-sensitive quantification of the therapeutic cyclic peptide bremelanotide utilizing UHPLC-MS/MS for evaluation of its oral plasma pharmacokinetics.

> PubMed lists PMID 32353679 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2020-03-27 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-32353679-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-08-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-32353679-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-32353679-bremelanotide-v1
- Content SHA-256: `8e1e63b058f87619f0727984113657fcd14d5549b62bd889b1c25d7ebba95ed9`

### Claims and source pins

#### Headline

Ultra-sensitive quantification of the therapeutic cyclic peptide bremelanotide utilizing UHPLC-MS/MS for evaluation of its oral plasma pharmacokinetics. ([`pubmed-observation-pmid-32353679-2024-08-01-64bb23e1c9c8`](#source-pubmed-observation-pmid-32353679-2024-08-01-64bb23e1c9c8))

#### Summary

PubMed lists PMID 32353679 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2020-03-27 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32353679-2024-08-01-64bb23e1c9c8`](#source-pubmed-observation-pmid-32353679-2024-08-01-64bb23e1c9c8))

#### Paragraph 1

PubMed lists PMID 32353679 in Journal of pharmaceutical and biomedical analysis as Journal Article, with publication-date metadata of 2020-03-27 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-32353679-2024-08-01-64bb23e1c9c8`](#source-pubmed-observation-pmid-32353679-2024-08-01-64bb23e1c9c8))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-32353679-2024-08-01-64bb23e1c9c8`](#source-pubmed-observation-pmid-32353679-2024-08-01-64bb23e1c9c8))

### Sources

<a id="source-pubmed-observation-pmid-32353679-2024-08-01-64bb23e1c9c8"></a>
- **Ultra-sensitive quantification of the therapeutic cyclic peptide bremelanotide utilizing UHPLC-MS/MS for evaluation of its oral plasma pharmacokinetics. · retained source version 1:2024-08-01:current:64bb23e1c9c8f11b6337187f517b58fd2462927360cf6103bafd4b901fd57a34** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/32353679/) (`pubmed-observation-pmid-32353679-2024-08-01-64bb23e1c9c8`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Ultra-sensitive quantification of the therapeutic cyclic peptide bremelanotide utilizing UHPLC-MS/MS for evaluation of its oral plasma pharmacokinetics." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-32353679-bremelanotide-v1 SHA-256: 8e1e63b058f87619f0727984113657fcd14d5549b62bd889b1c25d7ebba95ed9.

---

<a id="pubmed-pmid-33455598-bremelanotide-v1"></a>

## The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women.

> PubMed lists PMID 33455598 in CNS spectrums as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-01-18 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-33455598-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-06-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-33455598-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-33455598-bremelanotide-v1
- Content SHA-256: `4fc6b9623e3d79f37bd5485b472f4695b438546ed53129e5133f3df0a0b2dec9`

### Claims and source pins

#### Headline

The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women. ([`pubmed-observation-pmid-33455598-2022-06-27-9892b6829fd8`](#source-pubmed-observation-pmid-33455598-2022-06-27-9892b6829fd8))

#### Summary

PubMed lists PMID 33455598 in CNS spectrums as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-01-18 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33455598-2022-06-27-9892b6829fd8`](#source-pubmed-observation-pmid-33455598-2022-06-27-9892b6829fd8))

#### Paragraph 1

PubMed lists PMID 33455598 in CNS spectrums as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-01-18 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-33455598-2022-06-27-9892b6829fd8`](#source-pubmed-observation-pmid-33455598-2022-06-27-9892b6829fd8))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-33455598-2022-06-27-9892b6829fd8`](#source-pubmed-observation-pmid-33455598-2022-06-27-9892b6829fd8))

### Sources

<a id="source-pubmed-observation-pmid-33455598-2022-06-27-9892b6829fd8"></a>
- **The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women. · retained source version 1:2022-06-27:current:9892b6829fd8d121aa34f553e22fa491b627703b3fd97ce19276e0a78b01937b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/33455598/) (`pubmed-observation-pmid-33455598-2022-06-27-9892b6829fd8`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder in premenopausal women." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-33455598-bremelanotide-v1 SHA-256: 4fc6b9623e3d79f37bd5485b472f4695b438546ed53129e5133f3df0a0b2dec9.

---

<a id="pubmed-pmid-35076581-bremelanotide-v1"></a>

## Bremelanotide for Treatment of Female Hypoactive Sexual Desire.

> PubMed lists PMID 35076581 in Neurology international as Journal Article, Review, with publication-date metadata of 2022-01-04 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-35076581-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-01-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-35076581-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-35076581-bremelanotide-v1
- Content SHA-256: `92c470d55b544c613d727e0839db02720813530085b3504d2ed1e28fea2a9de9`

### Claims and source pins

#### Headline

Bremelanotide for Treatment of Female Hypoactive Sexual Desire. ([`pubmed-observation-pmid-35076581-2022-01-28-306c02855c39`](#source-pubmed-observation-pmid-35076581-2022-01-28-306c02855c39))

#### Summary

PubMed lists PMID 35076581 in Neurology international as Journal Article, Review, with publication-date metadata of 2022-01-04 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35076581-2022-01-28-306c02855c39`](#source-pubmed-observation-pmid-35076581-2022-01-28-306c02855c39))

#### Paragraph 1

PubMed lists PMID 35076581 in Neurology international as Journal Article, Review, with publication-date metadata of 2022-01-04 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35076581-2022-01-28-306c02855c39`](#source-pubmed-observation-pmid-35076581-2022-01-28-306c02855c39))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-35076581-2022-01-28-306c02855c39`](#source-pubmed-observation-pmid-35076581-2022-01-28-306c02855c39))

### Sources

<a id="source-pubmed-observation-pmid-35076581-2022-01-28-306c02855c39"></a>
- **Bremelanotide for Treatment of Female Hypoactive Sexual Desire. · retained source version 1:2022-01-28:current:306c02855c39b8a144562a49bc686e6f30ce22e7aeaf77363a541befd80ba0a0** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/35076581/) (`pubmed-observation-pmid-35076581-2022-01-28-306c02855c39`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Bremelanotide for Treatment of Female Hypoactive Sexual Desire." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-35076581-bremelanotide-v1 SHA-256: 92c470d55b544c613d727e0839db02720813530085b3504d2ed1e28fea2a9de9.

---

<a id="pubmed-pmid-35230162-bremelanotide-v1"></a>

## Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide.

> PubMed lists PMID 35230162 in Journal of women's health (2002) as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-02-25 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-35230162-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-03-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-35230162-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-35230162-bremelanotide-v1
- Content SHA-256: `f29fb3290be5bd2008535f116b967a9796a24e6bf6502c81fc7572263de84cb7`

### Claims and source pins

#### Headline

Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide. ([`pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e`](#source-pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e))

#### Summary

PubMed lists PMID 35230162 in Journal of women's health (2002) as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-02-25 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e`](#source-pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e))

#### Paragraph 1

PubMed lists PMID 35230162 in Journal of women's health (2002) as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-02-25 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e`](#source-pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e`](#source-pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e))

### Sources

<a id="source-pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e"></a>
- **Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide. · retained source version 1:2022-03-15:current:900a59f19c6ec3c2e62f436cec39fa89c6d909ecedce5887f501d4d6a698b301** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/35230162/) (`pubmed-observation-pmid-35230162-2022-03-15-900a59f19c6e`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Prespecified and Integrated Subgroup Analyses from the RECONNECT Phase 3 Studies of Bremelanotide." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-35230162-bremelanotide-v1 SHA-256: f29fb3290be5bd2008535f116b967a9796a24e6bf6502c81fc7572263de84cb7.

---

<a id="pubmed-pmid-36242769-bremelanotide-v1"></a>

## An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder.

> PubMed lists PMID 36242769 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2022-10-18 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-36242769-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2023-01-17
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-36242769-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-36242769-bremelanotide-v1
- Content SHA-256: `243ddb03de73dfbd3a27791a37558e527882d53169a13406c1e27ea09afc75a1`

### Claims and source pins

#### Headline

An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder. ([`pubmed-observation-pmid-36242769-2023-01-17-e635a689e632`](#source-pubmed-observation-pmid-36242769-2023-01-17-e635a689e632))

#### Summary

PubMed lists PMID 36242769 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2022-10-18 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36242769-2023-01-17-e635a689e632`](#source-pubmed-observation-pmid-36242769-2023-01-17-e635a689e632))

#### Paragraph 1

PubMed lists PMID 36242769 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2022-10-18 (day precision). PeptideScanner associated the retained record with the identity slug bremelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36242769-2023-01-17-e635a689e632`](#source-pubmed-observation-pmid-36242769-2023-01-17-e635a689e632))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-36242769-2023-01-17-e635a689e632`](#source-pubmed-observation-pmid-36242769-2023-01-17-e635a689e632))

### Sources

<a id="source-pubmed-observation-pmid-36242769-2023-01-17-e635a689e632"></a>
- **An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder. · retained source version 1:2023-01-17:current:e635a689e632def4788202d749b9f01a2ab1e24b7d5601125d9bf4de25e8b6dd** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/36242769/) (`pubmed-observation-pmid-36242769-2023-01-17-e635a689e632`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-36242769-bremelanotide-v1 SHA-256: 243ddb03de73dfbd3a27791a37558e527882d53169a13406c1e27ea09afc75a1.

---

<a id="pubmed-pmid-39793696-bremelanotide-v1"></a>

## PubMed record PMID 39793696

> PeptideScanner retained PubMed bibliographic metadata for PMID 39793696 at 2026-07-30T16:20:39.143Z. PubMed recorded a metadata revision date of 2026-05-24 and an Entrez history date of 2025-01-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-39793696-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-05-24
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39793696-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-39793696-bremelanotide-v1
- Content SHA-256: `46aefc58a5228526d6559983d701d3ef3bb04f1814f10ac6868f34afbcb13de7`

### Claims and source pins

#### Headline

PubMed record PMID 39793696 ([`pubmed-observation-pmid-39793696-2026-05-24-f98ca8628662`](#source-pubmed-observation-pmid-39793696-2026-05-24-f98ca8628662))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 39793696 at 2026-07-30T16:20:39.143Z. PubMed recorded a metadata revision date of 2026-05-24 and an Entrez history date of 2025-01-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39793696-2026-05-24-f98ca8628662`](#source-pubmed-observation-pmid-39793696-2026-05-24-f98ca8628662))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 39793696 at 2026-07-30T16:20:39.143Z. PubMed recorded a metadata revision date of 2026-05-24 and an Entrez history date of 2025-01-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-39793696-2026-05-24-f98ca8628662`](#source-pubmed-observation-pmid-39793696-2026-05-24-f98ca8628662))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39793696-2026-05-24-f98ca8628662`](#source-pubmed-observation-pmid-39793696-2026-05-24-f98ca8628662))

### Sources

<a id="source-pubmed-observation-pmid-39793696-2026-05-24-f98ca8628662"></a>
- **PubMed record PMID 39793696 · retained source version 1:2026-05-24:current:f98ca8628662cb78c535accc40c4eb927187ef2d676d353113c614b6b25c6f80** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39793696/) (`pubmed-observation-pmid-39793696-2026-05-24-f98ca8628662`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 39793696." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-39793696-bremelanotide-v1 SHA-256: 46aefc58a5228526d6559983d701d3ef3bb04f1814f10ac6868f34afbcb13de7.

---

<a id="pubmed-pmid-41960633-bremelanotide-v1"></a>

## PubMed record PMID 41960633

> PeptideScanner retained PubMed bibliographic metadata for PMID 41960633 at 2026-07-30T16:22:18.490Z. PubMed recorded a metadata revision date of 2026-04-24 and an Entrez history date of 2026-04-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-41960633-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-04-24
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41960633-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-41960633-bremelanotide-v1
- Content SHA-256: `749e7d82d7a4407ae5c67736965251b79c40b5ed16e7ad73971cd89b89388056`

### Claims and source pins

#### Headline

PubMed record PMID 41960633 ([`pubmed-observation-pmid-41960633-2026-04-24-f28d95898ff1`](#source-pubmed-observation-pmid-41960633-2026-04-24-f28d95898ff1))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 41960633 at 2026-07-30T16:22:18.490Z. PubMed recorded a metadata revision date of 2026-04-24 and an Entrez history date of 2026-04-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41960633-2026-04-24-f28d95898ff1`](#source-pubmed-observation-pmid-41960633-2026-04-24-f28d95898ff1))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 41960633 at 2026-07-30T16:22:18.490Z. PubMed recorded a metadata revision date of 2026-04-24 and an Entrez history date of 2026-04-10. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-41960633-2026-04-24-f28d95898ff1`](#source-pubmed-observation-pmid-41960633-2026-04-24-f28d95898ff1))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41960633-2026-04-24-f28d95898ff1`](#source-pubmed-observation-pmid-41960633-2026-04-24-f28d95898ff1))

### Sources

<a id="source-pubmed-observation-pmid-41960633-2026-04-24-f28d95898ff1"></a>
- **PubMed record PMID 41960633 · retained source version 1:2026-04-24:current:f28d95898ff19e62d42423a92221477d83130a86a8876cdba3966c3b3c123cc6** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41960633/) (`pubmed-observation-pmid-41960633-2026-04-24-f28d95898ff1`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 41960633." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-41960633-bremelanotide-v1 SHA-256: 749e7d82d7a4407ae5c67736965251b79c40b5ed16e7ad73971cd89b89388056.

---

<a id="pubmed-pmid-42485063-bremelanotide-v1"></a>

## PubMed record PMID 42485063

> PeptideScanner retained PubMed bibliographic metadata for PMID 42485063 at 2026-08-10T18:13:56.710Z. PubMed recorded a metadata revision date of 2026-07-22 and an Entrez history date of 2026-07-22. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-42485063-bremelanotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-22
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-11
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-42485063-bremelanotide/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-42485063-bremelanotide-v1
- Content SHA-256: `6a375a19ff2a307eb6be7531e2d99f23f2d6ff959bd5712dd115437b726c4383`

### Claims and source pins

#### Headline

PubMed record PMID 42485063 ([`pubmed-observation-pmid-42485063-2026-07-22-6e107e168b41`](#source-pubmed-observation-pmid-42485063-2026-07-22-6e107e168b41))

#### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 42485063 at 2026-08-10T18:13:56.710Z. PubMed recorded a metadata revision date of 2026-07-22 and an Entrez history date of 2026-07-22. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42485063-2026-07-22-6e107e168b41`](#source-pubmed-observation-pmid-42485063-2026-07-22-6e107e168b41))

#### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 42485063 at 2026-08-10T18:13:56.710Z. PubMed recorded a metadata revision date of 2026-07-22 and an Entrez history date of 2026-07-22. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-42485063-2026-07-22-6e107e168b41`](#source-pubmed-observation-pmid-42485063-2026-07-22-6e107e168b41))

#### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-42485063-2026-07-22-6e107e168b41`](#source-pubmed-observation-pmid-42485063-2026-07-22-6e107e168b41))

### Sources

<a id="source-pubmed-observation-pmid-42485063-2026-07-22-6e107e168b41"></a>
- **PubMed record PMID 42485063 · retained source version 1:2026-07-22:current:6e107e168b41e95cc6d150c9e1f75ba226e5321e382a3c6dae5243b02a3fa7de** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/42485063/) (`pubmed-observation-pmid-42485063-2026-07-22-6e107e168b41`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "PubMed record PMID 42485063." Version 1, published 2026-08-11. https://peptidescanner.com/evidence/v1/peptides/bremelanotide.json#pubmed-pmid-42485063-bremelanotide-v1 SHA-256: 6a375a19ff2a307eb6be7531e2d99f23f2d6ff959bd5712dd115437b726c4383.

